Armata Pharmaceuticals (ARMP) Other Accumulated Expenses (2016 - 2026)
Armata Pharmaceuticals (ARMP) posted Other Accumulated Expenses of $372000.0 for Q1 2026, down 23.61% sequentially from $487000.0 in Q4 2025, and up 10.39% YoY from $337000.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Other Accumulated Expenses for 6 years, with the latest figure at $372000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses rose 10.39% year-over-year to $372000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $372000.0 (up 10.39% YoY) and the FY2025 annual result came in at $487000.0, down 7.94% from the prior year.
- Other Accumulated Expenses retreated to $372000.0 in Q1 2026 per ARMP's latest filing, from $487000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $529000.0 in Q4 2024 and troughed at $124000.0 in Q2 2024.
- A 4-year average of $384700.0 and a median of $429500.0 in 2025 frame the typical range for Other Accumulated Expenses.
- The widest YoY moves for Other Accumulated Expenses: up 10.48% in 2025, down 7.94% in 2025.
- Over 4 years, Other Accumulated Expenses stood at $523000.0 in 2023, then advanced by 1.15% to $529000.0 in 2024, then retreated by 7.94% to $487000.0 in 2025, then slipped by 23.61% to $372000.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $372000.0, $487000.0, and $503000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 195,000.00 |
| Mar 31, 2026 | 372,000.00 |
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 503,000.00 |
| Jun 30, 2025 | 137,000.00 |
| Mar 31, 2025 | 337,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 124,000.00 |
| Mar 31, 2024 | 322,000.00 |
| Dec 31, 2023 | 523,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 408,000.00 |
| Mar 31, 2017 | 161,000.00 |
| Dec 31, 2016 | 185,000.00 |
| Sep 30, 2016 | 15,000.00 |
| Jun 30, 2016 | 15,000.00 |
| Mar 31, 2016 | 54,000.00 |